Correlation Between BiOasis Technologies and Inhibrx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BiOasis Technologies and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BiOasis Technologies and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between biOasis Technologies and Inhibrx, you can compare the effects of market volatilities on BiOasis Technologies and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BiOasis Technologies with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of BiOasis Technologies and Inhibrx.

Diversification Opportunities for BiOasis Technologies and Inhibrx

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between BiOasis and Inhibrx is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding biOasis Technologies and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and BiOasis Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on biOasis Technologies are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of BiOasis Technologies i.e., BiOasis Technologies and Inhibrx go up and down completely randomly.

Pair Corralation between BiOasis Technologies and Inhibrx

Assuming the 90 days horizon biOasis Technologies is expected to generate 11.74 times more return on investment than Inhibrx. However, BiOasis Technologies is 11.74 times more volatile than Inhibrx. It trades about 0.14 of its potential returns per unit of risk. Inhibrx is currently generating about 0.0 per unit of risk. If you would invest  0.01  in biOasis Technologies on December 20, 2024 and sell it today you would earn a total of  0.03  from holding biOasis Technologies or generate 300.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.16%
ValuesDaily Returns

biOasis Technologies  vs.  Inhibrx

 Performance 
       Timeline  
biOasis Technologies 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in biOasis Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BiOasis Technologies reported solid returns over the last few months and may actually be approaching a breakup point.
Inhibrx 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

BiOasis Technologies and Inhibrx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BiOasis Technologies and Inhibrx

The main advantage of trading using opposite BiOasis Technologies and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BiOasis Technologies position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.
The idea behind biOasis Technologies and Inhibrx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios